A detailed history of Fil LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fil LTD holds 275,509 shares of MRK stock, worth $27.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
275,509
Previous 317,770 13.3%
Holding current value
$27.2 Million
Previous $39.3 Million 20.47%
% of portfolio
0.03%
Previous 0.04%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $4.7 Million - $5.45 Million
-42,261 Reduced 13.3%
275,509 $31.3 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $2.78 Million - $2.98 Million
-22,446 Reduced 6.6%
317,770 $39.3 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $790,415 - $921,010
6,980 Added 2.09%
340,216 $44.9 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $7.69 Million - $8.37 Million
-76,737 Reduced 18.72%
333,236 $36.3 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $2.6 Million - $2.89 Million
-25,237 Reduced 5.8%
409,973 $42.2 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $39.1 Million - $42.6 Million
360,148 Added 479.8%
435,210 $50.2 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $7.73 Million - $8.62 Million
75,062 New
75,062 $7.99 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $10.2 Million - $11.3 Million
-142,891 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $296,567 - $328,033
4,218 Added 3.04%
142,891 $11.1 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $9.51 Million - $11.2 Million
138,052 Added 22230.6%
138,673 $10.7 Million
Q4 2020

Feb 08, 2021

SELL
$71.77 - $79.65 $10,980 - $12,186
-153 Reduced 19.77%
621 $51,000
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $3,512 - $3,981
48 Added 6.61%
774 $65,000
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $20.3 Million - $23.1 Million
-288,672 Reduced 99.75%
726 $56,000
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $1.77 Million - $2.45 Million
27,938 Added 10.69%
289,398 $22.3 Million
Q4 2019

Feb 07, 2020

SELL
$77.58 - $87.54 $45.4 Million - $51.2 Million
-585,437 Reduced 69.13%
261,460 $23.8 Million
Q3 2019

Nov 13, 2019

SELL
$76.08 - $82.93 $278 Million - $303 Million
-3,648,982 Reduced 81.16%
846,897 $71.3 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $72.7 Million - $84.9 Million
-1,040,769 Reduced 18.8%
4,495,879 $377 Million
Q1 2019

May 13, 2019

SELL
$69.58 - $79.36 $19 Million - $21.7 Million
-273,392 Reduced 4.71%
5,536,648 $460 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $27.3 Million - $31.7 Million
418,270 Added 7.76%
5,810,040 $444 Million
Q3 2018

Nov 09, 2018

BUY
$57.69 - $67.84 $31.3 Million - $36.8 Million
543,130 Added 11.2%
5,391,770 $382 Million
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $172 Million - $203 Million
3,392,140 Added 232.9%
4,848,640 $294 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $6.36 Million - $7.4 Million
-124,872 Reduced 7.9%
1,456,500 $79.3 Million
Q4 2017

Feb 12, 2018

SELL
$51.62 - $61.64 $10.9 Million - $13 Million
-211,710 Reduced 11.81%
1,581,372 $89 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $3.69 Million - $3.97 Million
62,917 Added 3.64%
1,793,082 $115 Million
Q2 2017

Aug 29, 2017

BUY
N/A
1,730,165
1,730,165 $111 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.